The stock traded at a 52-week high of Rs 5,024.5 and a low of Rs 3,300.0. The return on equity of the stock stood at 11.78 percent. So far, around 9,392 shares have been traded on the exchange.
The stock’s beta value, which measures its volatility relative to the broader market, stood at 1.0.
The stock has outperformed, up 33.64 percent over the past year compared to a 23.97 percent increase in Sensex.
Technicians
On the technical charts, the stock’s 200-day moving average (DMA) stood at Rs 3,300.0 on August 26, while the 50-day DMA stood at Rs 4,674.93. If a stock is trading well above the 50-day DMA and the 200-day DMA, it usually means that the immediate trend is bullish. On the other hand, if the stock is trading well below the 50-day DMA and the 200-day DMA, it is considered to be in a bearish trend and if it is trading between these averages, then it suggests that the stock can go in either direction.
Promoter/FII Holding
The promoters had a 51.9 percent stake in Divi Laboratories Ltd. As of June 30, 2024, mutual funds and foreign institutional investors held 13.1 percent and 16.16 percent stakes.
Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.